Thymalin vs Thymosin Alpha-1
Thymalin (Thymic peptide fraction) and Thymosin Alpha-1 (Immunomodulatory peptide (thymic)) are documented as co-studied in the PeptiDex library. This page puts the two entries side by side on class, molecular weight, half-life, origin, mechanism and studied research areas — every value taken from the entry it belongs to.
Why these two are co-studied
Cross-referenced for research context — not a usage or combination recommendation.
At a glance
| Attribute | Thymalin | Thymosin Alpha-1 |
|---|---|---|
| Compound class | Thymic peptide fraction | Immunomodulatory peptide (thymic) |
| Research category | Longevity & Cellular | Longevity & Cellular |
| Length (amino acids) | Not documented | 28 amino acids |
| Molecular weight | Not documented | 3108 g/mol (approx.) |
| Half-life | Not documented | ~2 hours (circulating) |
| Origin | Thymalin is a peptide preparation derived from a fraction of calf (bovine) thymus tissue, developed in Russia as a thymic bioregulator. It is a polypeptide/peptide complex rather than a single defined-sequence peptide. | Thymosin alpha-1 (Thymalfasin) is a 28-amino-acid peptide originally isolated from thymosin fraction 5 of thymic tissue and later produced synthetically. It corresponds to a fragment of the precursor protein prothymosin alpha and is naturally acetylated at its N-terminus. |
“Not documented” means the PeptiDex entry records no value for that field. Nothing on this page is estimated, and no figure is carried over from one compound to the other.
How Thymalin works
Thymalin is described as a thymic peptide preparation reported to modulate immune function, particularly influencing T-lymphocyte differentiation and the balance of immune cell populations. As a mixture of thymic peptides, its actions are attributed to restoring or regulating immune parameters in preclinical and clinical research from the Russian literature. The precise molecular targets are not fully defined given its nature as a peptide fraction.
How Thymosin Alpha-1 works
Thymosin alpha-1 acts as an immunomodulator, reported to enhance T-cell maturation and function, influence dendritic cell activity, and modulate innate immune signaling including Toll-like receptor pathways. It has been studied for augmenting responses to antigens and vaccines and for regulating immune responses in infection and cancer contexts. Its effects are attributed to broad immune-regulating activity rather than a single narrowly defined receptor.
Mechanistic descriptions reflect published research-literature understanding and are quoted from each compound's own entry. Much peptide research is preclinical (in-vitro or animal-model); mechanism in humans may differ and is not established for many compounds.
Where each one appears in the literature
The research contexts each entry documents. Listing a research area is not a claim of efficacy or a therapeutic indication, and the two lists are not scored against each other.
Thymalin
Thymosin Alpha-1
What sets each apart
Thymalin
Unlike Thymosin alpha-1 (a single, defined 28-residue peptide), Thymalin is a multi-peptide thymic tissue fraction, so it has no single sequence or molecular weight.
Thymosin Alpha-1
Thymosin alpha-1 is a single, well-characterized synthetic peptide with genuine clinical trial data and approvals in some countries, unlike the research-only thymic fraction Thymalin.
Frequently asked questions
How does thymalin differ from thymosin alpha-1?
Thymosin alpha-1 is a single, chemically defined 28-amino-acid peptide with a known sequence, whereas thymalin is a defined-process but undefined-composition extract containing a mixture of thymic peptides. Batch-to-batch peptide ratios can vary in thymalin, unlike the single synthetic molecule of thymosin alpha-1.
What is thymalin?
Thymalin is a low-molecular-weight polypeptide fraction extracted from calf (bovine) thymus, developed in Russia by Khavinson and Morozov. It is a heterogeneous complex of short peptides rather than a single defined molecule, and is studied as an immunomodulator that reportedly normalizes rather than simply boosts immune parameters.
What is thymalin studied for?
Thymalin is studied in immune-senescence and aging research for reported restoration of T-cell counts, CD4/CD8 ratios, and NK-cell activity in older populations. Khavinson-era observational studies also reported reduced mortality in elderly cohorts, though these were non-randomized and are considered preliminary.
How does thymosin alpha-1 differ from thymalin?
Thymosin alpha-1 is a single, synthetically defined 28-mer with a known sequence and molecular weight, whereas thymalin is an undefined-composition thymic extract. Researchers choose thymosin alpha-1 when a standardized, single-molecule immunomodulator is needed.
What is thymosin alpha-1?
Thymosin alpha-1 (Ta1, thymalfasin, brand Zadaxin) is an acetylated 28-amino-acid thymic peptide that acts as an immunomodulator. It is studied for enhancing T-cell maturation and dendritic-cell function, in part through Toll-like receptor signaling (TLR9/TLR2).
What is the sequence and molecular weight of thymosin alpha-1?
Its sequence is Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN, a 28-residue N-acetylated peptide with a molecular weight of about 3108 Da. The N-terminal acetylation is a defining structural feature of the native molecule.
Answers are the ones published on each compound's own PeptiDex entry. They are educational summaries of research-literature context and are not medical advice.